Compare MPB & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MPB | INMD |
|---|---|---|
| Founded | 1868 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 856.0M | 842.0M |
| IPO Year | 1996 | 2018 |
| Metric | MPB | INMD |
|---|---|---|
| Price | $32.71 | $13.92 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 5 |
| Target Price | ★ $37.00 | $17.33 |
| AVG Volume (30 Days) | 107.3K | ★ 919.7K |
| Earning Date | 04-21-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.66% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.36 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $30.95 | $1.74 |
| Revenue Next Year | $9.45 | $3.26 |
| P/E Ratio | $90.72 | ★ $10.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $25.83 | $12.72 |
| 52 Week High | $35.22 | $16.74 |
| Indicator | MPB | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 50.68 | 48.25 |
| Support Level | $30.66 | $13.71 |
| Resistance Level | $34.88 | $14.70 |
| Average True Range (ATR) | 0.77 | 0.28 |
| MACD | 0.10 | -0.01 |
| Stochastic Oscillator | 78.30 | 51.49 |
Mid Penn Bancorp Inc is a financial holding company, providing various banking and financial products and services through its subsidiaries. These products and services mainly include consumer banking products, including secure checking and savings accounts, mobile banking, agricultural loans, construction financing, mortgages, home equity loans and lines of credit, credit cards, and more. Additionally, the Group offers trust services, insurance products, wealth management, and private banking services. The Group caters to individuals, partnerships, non-profit organizations, and corporations through its retail banking offices located throughout Pennsylvania, with a minor portion in New Jersey.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.